These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms]. Allocati N, Catamo G, Cellini L. Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1927-33. PubMed ID: 6440583 [Abstract] [Full Text] [Related]
23. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Kresken M, Wiedemann B. Antimicrob Agents Chemother; 1988 Aug 30; 32(8):1285-8. PubMed ID: 3142353 [Abstract] [Full Text] [Related]
26. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents. Body BA, Fromtling RA, Shadomy S, Shadomy HJ. Eur J Clin Microbiol; 1983 Jun 30; 2(3):230-4. PubMed ID: 6224678 [Abstract] [Full Text] [Related]
27. [Influence of technical factors in the determination of minimal inhibitory concentration by microdilution]. Forey F, Coulet M, Brun Y, Fleurette J. Pathol Biol (Paris); 1985 May 30; 33(5):341-9. PubMed ID: 3162138 [Abstract] [Full Text] [Related]
28. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance. Corigliano BE, Appleman MD, Heseltine PN, Leedom JM. Diagn Microbiol Infect Dis; 1984 Apr 30; 2(2):101-6. PubMed ID: 6232085 [Abstract] [Full Text] [Related]
31. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants. Cullmann W, Stieglitz M, Baars B, Opferkuch W. Chemotherapy; 1985 Apr 30; 31(1):19-28. PubMed ID: 3156025 [Abstract] [Full Text] [Related]
32. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim]. Lebek G, Wiedmer E. Schweiz Med Wochenschr; 1971 Sep 25; 101(38):1385-90. PubMed ID: 4946735 [No Abstract] [Full Text] [Related]
33. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens. Digranes A, Dibb WL, Ostervold B. Acta Pathol Microbiol Immunol Scand B; 1984 Apr 25; 92(2):101-6. PubMed ID: 6233841 [Abstract] [Full Text] [Related]
34. Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora. Schaeffer AJ, Sisney GA. J Urol; 1985 Apr 25; 133(4):628-30. PubMed ID: 3157008 [Abstract] [Full Text] [Related]
35. [Nitrofurans: a modern treatment for uncomplicated urinary infections?]. Cahen P, Honderlick P. Pathol Biol (Paris); 2000 Jun 25; 48(5):470-1. PubMed ID: 10949843 [Abstract] [Full Text] [Related]
36. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins]. Croize J, Le Noc P, Bryskier A, Robert J. Pathol Biol (Paris); 1985 Jun 25; 33(5 Pt 2):564-8. PubMed ID: 3937128 [Abstract] [Full Text] [Related]
40. [Antibacterial action of septrin in vitro against microorganisms causing urinary tract infections in comparison with their sensitivity to other chemotherapeutic and antibiotic drugs]. Ganczarski A, Augustyniak G, Brauner G, Prelich A, Stapor K. Przegl Lek; 1973 Jun 25; 30(3):303-7. PubMed ID: 4633373 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]